Suppression of cellular immunity in rats and mice by maternal treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
D000818:Animals; D001724:Birth Weight / Q000187:drug effects; D002722:Chlorobenzenes / Q000494:pharmacology; D004147:Dioxins / Q000494:pharmacology*; D005260:Female; D006084:Graft Rejection; D006087:Graft vs Host Reaction; D007111:Immunity, Cellular / Q000187:drug effects*; D007166:Immunosuppressive Agents; D037102:Lectins; D008213:Lymphocyte Activation; D008212:Lymphocyte Depletion; D008431:Maternal-Fetal Exchange; D051379:Mice; D008810:Mice, Inbred C57BL; D009929:Organ Size; D011247:Pregnancy; D051381:Rats; D016038:Skin Transplantation; D013154:Spleen / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D013950:Thymus Gland / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D014184:Transplantation, Homologous
D002722:Chlorobenzenes; D004147:Dioxins; D007166:Immunosuppressive Agents; D037102:Lectins